ABSTRACT
Since 1988 250 patients had occluded peripheral arteries reopened by an Argon laser. The mean age of the 110 men and 85 women was 71 years and the mean length of all occlusions 13.4 cm. The primary success rate was 81.5% with a perforation rate of less than 2%. The patency rate after 96 weeks was 80%.
Subject(s)
Angioplasty, Laser , Arterial Occlusive Diseases/therapy , Leg/blood supply , Aged , Female , Humans , Male , Middle Aged , RecurrenceABSTRACT
For many years great efforts are being made to recanalise totally occluded vessels and averting a bypass operation as long as possible. In two years 190 patients were treated successfully by the Lastac System. Encouraged by very good results, we started to recanalise the totally occluded superficial femoral artery via a transpopliteal approach. Meanwhile, 29 patients were treated. Primary successful were 22 patients with an average length of a total occlusion of 27.5 cm.
Subject(s)
Angioplasty, Laser , Arterial Occlusive Diseases/surgery , Femoral Artery , Adult , Aged , Female , Humans , Male , Middle AgedABSTRACT
A new Argonlaser developed in the United States of America is available to the radiological and surgical departments of the Hospital of St. Pölten. It is used for recanalization of totally occluded peripheral arteries. During the last 9 months, 51 patients (30 men and 21 women) with an average age of 71 years have been treated. Total occlusion was present in 88% of the arteries treated. The primary success rate is 89%, and the perforation rate is under 2%.
Subject(s)
Angioplasty, Balloon/methods , Arterial Occlusive Diseases/therapy , Laser Therapy , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle AgedSubject(s)
Cefotaxime/analogs & derivatives , Cefuroxime/therapeutic use , Cephalosporins/therapeutic use , Gentamicins/therapeutic use , Netilmicin/therapeutic use , Premedication , Surgical Wound Infection/prevention & control , Vascular Surgical Procedures , Aged , Cefotaxime/therapeutic use , Ceftriaxone , Clinical Trials as Topic , Female , Humans , Male , Middle Aged , Prospective Studies , Random AllocationABSTRACT
The influence of incubation with D-penicillamine on pure enzyme preparations and on enzymatic activities of serum and skin homogenates was investigated. Three of the nine enzymatic activities studied underwent significant changes. Such effects of D-penicillamine must be taken into consideration if therapeutic or unwanted actions of this drug are to be fully understood; they are elicited by concentrations reached under conditions used for human therapy.
